Novartis (NVS) has sealed a $3.1 billion deal to acquire clinical-stage biopharmaceutical company Anthos Therapeutics.

We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to ...

ISRO's NVS-02 satellite fails to reach geostationary orbit due to valve failure, impacting NavIC and Gaganyaan missions.

Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...

Novartis (NYSE:NVS – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating ...

According to the latest update by Isro, the NVS-02 navigation satellite, which was launched on Wednesday (January 29), could not complete its orbit-raising operations after it failed to ignite a fire ...

Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

ISRO launches historic 100th mission from Sriharikota, placing NVS-02 satellite in orbit for NavIC regional navigation system ...

Despite the issue, ISRO assured that the NVS-02 navigation satellite was successfully injected into the intended ...

The engine was developed by ISRO's Liquid Propulsion Systems Centre. Meanwhile, ISRO has formed a committee headed by former ...

The satellite, which is intended to bolster India's navigation capabilities, faced a problem during the 'orbit-raising ...